Creative Planning
MYOV

Creative Planning’s Myovant Sciences Ltd. MYOV Stock Holding History

Creative Planning’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-27,245
Closed -$489K – 2644
2022
Q3 		$489K Buy
+27,245
New +$435K ﹤0.01% 1346
2021
Q1 		– Sell
-20,900
Closed -$577K – 2769
2020
Q4 		$577K Buy
20,900
+3,200
+18% +$62.3K ﹤0.01% 1235
2020
Q3 		$249K Buy
+17,700
New +$329K ﹤0.01% 1551
2020
Q1 		– Sell
-11,818
Closed -$183K – 2139
2019
Q4 		$183K Buy
+11,818
New +$119K ﹤0.01% 1661
2017
Q3 		– Sell
-2,400
Closed -$28K – 3968
2017
Q2 		$28K Buy
+2,400
New +$29.7K ﹤0.01% 2945

Other funds holding MYOV

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Creative Planning's MYOV Position: Q4 2022 in Review

Creative Planning sold out of Myovant Sciences Ltd. (MYOV) in Q4 2022, closing a stake of 27,245 shares — an estimated $489K sold.

Creative Planning first reported a position in MYOV in Q2 2017 and held it in 5 quarters. The position peaked at $577K in Q4 2020. 118 funds tracked by Wall St. Rank hold MYOV as of Q4 2022.

  • Creative Planning reported no remaining Myovant Sciences Ltd. position as of Q4 2022 after selling out during the quarter.
  • Creative Planning sold 27,245 Myovant Sciences Ltd. shares in Q4 2022, an estimated $489K.
  • Creative Planning first reported a position in Myovant Sciences Ltd. in Q2 2017 and held it in 5 quarters.
  • Creative Planning's Myovant Sciences Ltd. position peaked at $577K in Q4 2020.
  • 118 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2022.

Based on Creative Planning's 13F filing for Q4 2022, filed 10 Feb 2023.